Intrinsic Value of S&P & Nasdaq Contact Us

Alpha Tau Medical Ltd. DRTSW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
40/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Alpha Tau Medical Ltd. (DRTSW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $-0.45 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.45 vs est $-0.45 (beat +0%). 2025: actual $-0.53 vs est $-0.51 (missed -3.8%). Analyst accuracy: 98%.

EPS Estimates — DRTSW

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.45 vs Est –$0.45 ▼ 0.0% off
2025 Actual –$0.53 vs Est –$0.51 ▼ 3.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — DRTSW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message